EPHA2 and neoplasm: Therefore, in the context of bone cell–tumor cell interactions, we hypothesized that blocking EphA2 will result in a decrease of osteoclast differentiation and activation, thus breaking the vicious cycle and offering an effective means to control bone metastasis.